Phage therapy

Acinetobacter baumannii
#Antibiotic resistance #Antimicrobial resistance (AMR) #Bacteriophage #Phage therapy

Superbug map supports ‘off-the-shelf’ region-specific phage therapies

Scientists have created a global ‘superbug map’ for one of the most dangerous superbug species, Acinetobacter baumannii, which will aid the development of lifesaving bacteriophage (phage) therapies. In a paper published in the journal Cell, an international collaboration led by scientists at the… Read More

#News

Bacteriophage
#Bacteriophage #Graft vs Host Disease #Japan #Phage therapy #Stem cell transplant

Bacteriophage study offers new hope in treating GVHD

Researchers from Japan have identified a bacteriophage-derived enzyme that holds promise for future applications in preventing or treating acute graft-versus-host disease (aGVHD). Acute GVHD is a medical condition that occurs when donor immune cells attack the recipient’s tissues after an allogeneic hematopoietic stem cell transplantation (allo-HCT). Read More

#News

#AI #Antimicrobial resistance (AMR) #Bioscience #Drug development #Europe #Phage therapy #Research

Grant will allow development of phage therapy diagnostic platform 

Vésale Bioscience, a company in the research and development of solutions and treatments using phage therapy for multi-resistant infections, has received €1.8 million in grants from the European Innovation Council (EIC) Accelerator Fund for its PhageDiag project.  The project is a phagogram using artificial intelligence (AI) that… Read More

#News